Israel Israel

29 Sep 2005

Citigroup, Deutsche Bank and SMBC have signed Teva Pharmaceuticals' $350m loan, which was increased from $150m following an oversubscription.
The deal comprises a $175m three year tranche paying 45bp over Libor and a $175m five year tranche paying Libor plus 55bp.
The other participants ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.